A robust in vivo xenograft model of STAT3-deficient tumor cell lines with adoptive transfer of human primary NK cells would be necessary to further elucidate the impact of STAT3 on NKG2D-mediated NK-cell surveillance. The gene discussed is STAT3; the disease is neoplasm.